Endoglin, PlGF and sFlt‐1 as markers for predicting pre‐eclampsia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Acta Obstetricia et Gynecologica Scandinavica

• Publication date

  2008-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00016340802253759PMID 18607829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

  2007cited by this paper
• Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.

  2007cited by this paper
• Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.

  2007cited by this paper
• Angiogenic factors for the prediction of preeclampsia in high-risk women.

  2007cited by this paper
• Vascular endothelial growth factor family of ligands and receptors: review.

  2007cited by this paper
• Placental Growth Factor and Soluble FMS-Like Tyrosine Kinase-1 in Early-Onset and Late-Onset Preeclampsia

  2007cited by this paper
• Alterations in Placental Growth Factor Levels before and after the Onset of Preeclampsia Are More Pronounced in Women with Early Onset Severe Preeclampsia

  2007cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• Urinary Placental Growth Factor and Risk of Preeclampsia

  2006cited by this paper
• Soluble endoglin contributes to the pathogenesis of preeclampsia

  2006cited by this paper
• Adiponectin and insulin resistance in early‐ and late‐onset pre‐eclampsia

  2006cited by this paper
• Prediction of Preeclampsia

  2005cited by this paper
• Latest Advances in Understanding Preeclampsia

  2005cited by this paper
• Pre-eclampsia

  2005cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Sex‐specific antenatal reference growth charts for uncomplicated singleton pregnancies at 15–40 weeks of gestation

  2004cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

  2003cited by this paper
• Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

  2003cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria*

  2003cited by this paper
• Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.

  2002cited by this paper
• Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.

  2000cited by this paper
• Pre-eclampsia

  2000cited by this paper
• Structure, expression and receptor-binding properties of placenta growth factor (PlGF).

  1999cited by this paper
• Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

  1990cited by this paper
• Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013A Role for Endoglin in Coupling eNOS Activity and Regulating Vascular Tone Revealed in Hereditary

  year unknowncited by this paper

• Linking Glomerular Endothelial Dysfunction with Urinary KIM-1, sFlt-1, Serum IL-10, and Regulatory T Cells in Preeclampsia

  2026cites this paper
• Late vs. Early Preeclampsia

  2025cites this paper
• Prevention of Pre-Eclampsia: Modern Strategies and the Role of Early Screening

  2025cites this paper
• Genetic factors in the risk assessment of preeclampsia: a review of recent findings

  2025cites this paper
• Predictive Performance of sFlt-1, PlGF and the sFlt-1/PlGF Ratio for Preeclampsia: A Systematic Review and Meta-Analysis.

  2025cites this paper
• The Role of Angiogenetic Factors in Preeclampsia

  2025cites this paper
• Differences in lymphocyte subsets of spiral artery associated with impaired vascular remodeling in hypertensive disorders of pregnancy

  2025cites this paper
• Pomegranate Juice Alleviates Preeclampsia Symptoms in an L-NAME-Induced Rat Model: A Dose-Dependent Study

  2025cites this paper
• Association between Maternal and Fetal Genetic Variants and Preeclampsia: Evidence from a Meta-Analysis

  2024cites this paper
• Placental biomarkers in second trimester maternal serum are associated with postpartum hemorrhage: a secondary analysis of the NuMoM2b dataset

  2024cites this paper
• Real-Time Signal Analysis with Wider Dynamic Range and Enhanced Sensitivity in Multiplex Colorimetric Immunoassays Using Encoded Hydrogel Microparticles.

  2024cites this paper
• Soluble endoglin as a diagnosis glycoprotein in preeclampsia

  2024cites this paper
• Discussion on the evaluation of the therapeutic efficacy of uterine artery blood flow parameters and serum PLGF and sFlt-1 in patients with recurrent spontaneous abortion

  2024cites this paper
• sFlt-1/PLGF ratio: A promising marker for early detection of preeclampsia in the second and third trimester

  2024cites this paper
• Role of hematological indices in predicting preeclampsia and its severity: retrospective case–control study

  2024cites this paper
• Evaluation of maternal serum vascular endothelial growth factor C and D levels in intrahepatic cholestasis of pregnancy

  2023cites this paper
• High-fat, high-carbohydrate diet-induced prediabetes preconception in Sprague–Dawley rats as a risk factor for the development of preeclampsia: assessing changes in placental metabolic insults

  2023cites this paper
• Combination of Maternal Serum ESM-1 and PLGF with Uterine Artery Doppler PI for Predicting Preeclampsia

  2023cites this paper
• Comparison of clinical outcomes and biochemical markers in normal and preeclamptic pregnancies: a prospective cohort study

  2023cites this paper
• Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: An update (Review)

  2023influential citation
• Longitudinal Associations between Ambient Air Pollution and Angiogenic Biomarkers among Pregnant Women in the LIFECODES Study, 2006–2008

  2023cites this paper
• Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia

  2023cites this paper
• Maternal Serum Soluble Endoglin Levels as a biomarker in Preeclampsia: A Case Control Tertiary Care Hospital Based Study

  2022cites this paper
• Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers

  2022cites this paper
• CONCENTRATINON OF ANTI – ANGIOGENIC FACTOR INPREGNANT WOMEN IN THE FIRST TRIMESTER OF PREGNANCY MANAGEMENT OF TEMPLE AT

  2022cites this paper
• The association of serum total bile acid with new-onset hypertension during pregnancy

  2022cites this paper
• Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: A systematic review and meta-analysis.

  2021cites this paper
• MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study

  2021cites this paper
• Association of Elevated Maternal Serum Total Bile Acids With Low Birth Weight and Intrauterine Fetal Growth Restriction

  2021cites this paper
• Review

  2021cites this paper
• Exploration of the Underlying Nutritional, Inflammatory and Oxidative Stress Pathological Mechanisms in Preeclampsia using Principal Component Analysis

  2021cites this paper
• Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004–2020 period: a systematic review

  2021cites this paper
• SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia

  2021cites this paper
• Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia

  2020cites this paper
• Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition

  2020cites this paper
• sFlt-1 value predicts pregnancy prolongation periods from diagnosis in pregnant women diagnosed with early-onset preeclampsia

  2020cites this paper
• Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses

  2020cites this paper
• Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis

  2020cites this paper
• Genomic and Postgenomic Technologies in Preeclampsia Genetics

  2020cites this paper
• Expert consensus: Indication criteria and screening strategy for preeclampsia using the serum sFlt-1/PlGF ratio at 18–36 weeks of gestation in women at imminent/basal risk of preeclampsia under insurance coverage

  2020cites this paper
• Mangiferin ameliorates placental oxidative stress and activates PI3K/Akt/mTOR pathway in mouse model of preeclampsia

  2020cites this paper
• Renal biomarkers of preeclampsia

  2020cites this paper
• Precipitation-based colorimetric multiplex immunoassay in hydrogel particles.

  2020cites this paper
• An Insight into the Angiogenic and Lymphatic Interplay in Pre-eclampsia Comorbid with HIV Infection

  2020cites this paper
• Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies

  2019cites this paper
• Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia

  2019cites this paper
• DIFFERENTIAL DIAGNOSTICS OF PREECLAMPSIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  2019cites this paper
• Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis

  2019cites this paper
• NEW BIOCHEMICAL MARKERS FOR PREECLAMPSIA-A MINI REVIEW

  2019cites this paper
• The prediction of early preeclampsia: Results from a longitudinal proteomics study

  2019cites this paper
• Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia

  2019cites this paper
• A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia

  2019cites this paper
• The profiles of soluble adhesion molecules in the “great obstetrical syndromes”*

  2019cites this paper
• Therapeutic effect of al-Quran murattal on anxiety, sFlt-1, PIGF and sFlt-1/PIGF ratio in pregnant women with risk of preeclampsia

  2019cites this paper
• Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers.

  2019cites this paper
• Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1–Induced Preeclampsia Phenotype in Mice

  2018cites this paper
• Fetal—Not Maternal—APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry

  2018cites this paper
• Is 8% O2 more normoxic than 21% O2 for long-term in vitro cultures of human primary term cytotrophoblasts?

  2018cites this paper
• Histopathological findings of pregnancy-induced hypertension: histopathology of early-onset type reflects two-stage disorder theory

  2018cites this paper
• Prädiktion der Präeklampsie mit Hilfe der Biomarker sFlt-1 und PlGF

  2018cites this paper
• The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16–20 Weeks Gestation

  2018cites this paper
• sFlt-1/PLGF

  2018cites this paper
• Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia

  2018cites this paper
• Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy

  2018cites this paper
• Serum sFlt-1/PlGF ratio has better diagnostic ability in early- compared to late-onset pre-eclampsia

  2018cites this paper
• Celastrol attenuates symptoms of preeclampsia in rats by inhibiting matrix metalloproteinase‐9

  2018cites this paper
• The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.

  2018cites this paper
• Glucocorticoid signaling regulates cell invasion and migration in the human first‐trimester trophoblast cell line Sw.71

  2018cites this paper
• Hypertension, augmented activity of matrix metalloproteinases‐2 and ‐9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline

  2018cites this paper
• Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study

  2018cites this paper
• Anti-angiogenesis and Preeclampsia in 2016

  2017cites this paper
• The influence of prenatal exercise and pre-eclampsia on maternal vascular function.

  2017cites this paper
• Circulating soluble endoglin modifies the inflammatory response in mice

  2017cites this paper
• Endoplasmic reticulum stress responses in placentation - A true balancing act.

  2017cites this paper
• Ferulic acid alleviates symptoms of preeclampsia in rats by upregulating vascular endothelial growth factor

  2017cites this paper
• Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips *

  2017cites this paper
• Chapter Fourteen – Biomarkers in Preeclampsia

  2017cites this paper
• Plasma levels of miR-19-5 p correlate with sFLT-1 levels in gestational diabetes mellitus

  2017cites this paper
• Prevalence, Risk Factors, and Pregnancy Outcomes of Early-onset Severe Preeclampsia among Severe Preeclamptic Women in Siriraj Hospital

  2017cites this paper
• Liver Disease Associated to Pregnancy in the Critically Ill Obstetric Patient: Pregnancy Associated Liver Dysfunction

  2017cites this paper
• Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity

  2017cites this paper
• Antagonis Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) dan Soluble Endoglin (sEng) pada Preeklamsia

  2017cites this paper
• The Role Of Pparγ In Placental Development And Disease

  2017cites this paper
• Plasma levels of miR-19-5p correlate with sFLT-1 levels in gestational diabetes mellitus

  2017cites this paper
• Sleep disordered breathing controlled by CPAP and sFlt-1 in a pregnant patient with chronic hypertension: Case report and literature review

  2017cites this paper
• Role of angiopoietin-2, endoglin, and placental growth factor in HIV-associated preeclampsia

  2017cites this paper
• Association between angiogenic factors and signs of arterial aging in women with pre‐eclampsia

  2017cites this paper
• Blood-based biomarkers of adverse perinatal outcomes in maternal obesity

  2017influential citation
• Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia?

  2017cites this paper
• The role of hematological and biochemical markers in preeclampsia prediction

  2017cites this paper
• Brain Structural and Vascular Anatomy Is Altered in Offspring of Pre-Eclamptic Pregnancies: A Pilot Study

  2016cites this paper
• Longitudinal changes in maternal serum placental growth factor and soluble fms‐like tyrosine kinase‐1 in women at increased risk of pre‐eclampsia

  2016cites this paper
• Simple quantitation for potential serum disease biomarker peptides, primarily identified by a peptidomics approach in the serum with hypertensive disorders of pregnancy

  2016cites this paper
• Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.

  2016cites this paper
• Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

  2016cites this paper
• Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia

  2016cites this paper
• Evaluation of Platelets Count and Indices in Pre-Eclampsia Compared to Normal Pregnancies

  2016cites this paper
• Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population

  2016cites this paper
• Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort

  2016cites this paper